Search Results - "Stremler, KE"
-
1
Soluble tumor necrosis factor (TNF) receptors are effective therapeutic agents in lethal endotoxemia and function simultaneously as both TNF carriers and TNF antagonists
Published in The Journal of immunology (1950) (01-08-1993)“…Two forms (monomeric or dimeric) of the extracellular, ligand-binding portion of the human p80 cell-surface receptor for TNF were used to antagonize TNF…”
Get full text
Journal Article -
2
Human plasma platelet-activating factor acetylhydrolase. Oxidatively fragmented phospholipids as substrates
Published in The Journal of biological chemistry (15-06-1991)“…Human plasma platelet-activating factor (PAF) acetylhydrolase hydrolyzes the sn-2 acetyl residue of PAF, but not phospholipids with long chain sn-2 residues…”
Get full text
Journal Article -
3
Oxidatively fragmented phosphatidylcholines activate human neutrophils through the receptor for platelet-activating factor
Published in The Journal of biological chemistry (15-06-1991)“…Platelet-activating factor (PAF, 1-O-alkyl-2-acetyl-sn-glycero-3-phosphocholine) activates neutrophils (polymorphonuclear leukocytes, PMN) through a receptor…”
Get full text
Journal Article -
4
Phosphorylation of isoprenoid alcohols
Published in Journal of organic chemistry (01-12-1986)Get full text
Journal Article -
5
An Oxidized Derivative of Phosphatidylcholine is a Substrate for the Platelet-Activating Factor Acetylhydrolase from Human Plasma
Published in The Journal of biological chemistry (05-04-1989)“…Platelet-activating factor (PAF) is a glycerophospho-lipid that has diverse potent biological actions. A plasma enzyme catalyzes the hydrolysis of the sn-2…”
Get full text
Journal Article -
6
Oxidatively fragmented phosphatidylcholines activate human neutrophils through the receptor for platelet-activating factor
Published in The Journal of biological chemistry (01-01-1991)“…Platelet-activating factor (PAF, 1-O-alkyl-2-acetyl-sn-glycero-3-phosphocholine) activates neutrophils (polymorphonuclear leukocytes, PMN) through a receptor…”
Get full text
Journal Article -
7
Characterization of the microheterogeneities of PIXY321, a genetically engineered granulocyte‐macrophage colony‐stimulating factor/interleukin‐3 fusion protein expressed in yeast
Published in European journal of biochemistry (01-02-1998)“…PIXY321, a human cytokine analog genetically engineered by the fusion of granulocyte‐macrophage colony‐stimulating factor (GM‐CSF) and interleukin‐3 (IL‐3),…”
Get full text
Journal Article -
8